Difference between revisions of "Eosinophilic fasciitis"
Jump to navigation
Jump to search
| Line 4: | Line 4: | ||
Clinical: | Clinical: | ||
*Onset typically preceded by strenuous exercise or labour.<ref name=pmid30910631>{{cite journal |vauthors=Ihn H |title=Eosinophilic fasciitis: From pathophysiology to treatment |journal=Allergol Int |volume=68 |issue=4 |pages=437–439 |date=October 2019 |pmid=30910631 |doi=10.1016/j.alit.2019.03.001 |url=}}</ref> | *Onset typically preceded by strenuous exercise or labour.<ref name=pmid30910631>{{cite journal |vauthors=Ihn H |title=Eosinophilic fasciitis: From pathophysiology to treatment |journal=Allergol Int |volume=68 |issue=4 |pages=437–439 |date=October 2019 |pmid=30910631 |doi=10.1016/j.alit.2019.03.001 |url=}}</ref> | ||
*" | *Skin induration with "orange peel" appearance.<ref name=pmid36768300/> | ||
*Eosinophilia. | *Eosinophilia.<ref name=pmid36768300/> | ||
Treatment:<ref name=pmid29101481>{{cite journal |authors=Mazori DR, Femia AN, Vleugels RA |title=Eosinophilic Fasciitis: an Updated Review on Diagnosis and Treatment |journal=Curr Rheumatol Rep |volume=19 |issue=12 |pages=74 |date=November 2017 |pmid=29101481 |doi=10.1007/s11926-017-0700-6 |url=}}</ref> | Treatment:<ref name=pmid29101481>{{cite journal |authors=Mazori DR, Femia AN, Vleugels RA |title=Eosinophilic Fasciitis: an Updated Review on Diagnosis and Treatment |journal=Curr Rheumatol Rep |volume=19 |issue=12 |pages=74 |date=November 2017 |pmid=29101481 |doi=10.1007/s11926-017-0700-6 |url=}}</ref> | ||
| Line 17: | Line 17: | ||
Note: | Note: | ||
*Require en bloc biopsies from the skin to the fascia.<ref name=pmid30910631>{{cite journal |vauthors=Ihn H |title=Eosinophilic fasciitis: From pathophysiology to treatment |journal=Allergol Int |volume=68 |issue=4 |pages=437–439 |date=October 2019 |pmid=30910631 |doi=10.1016/j.alit.2019.03.001 |url=}}</ref> | *Require en bloc biopsies from the skin to the fascia.<ref name=pmid30910631>{{cite journal |vauthors=Ihn H |title=Eosinophilic fasciitis: From pathophysiology to treatment |journal=Allergol Int |volume=68 |issue=4 |pages=437–439 |date=October 2019 |pmid=30910631 |doi=10.1016/j.alit.2019.03.001 |url=}}</ref> | ||
==See also== | |||
*[[Eosinophil]]. | |||
==References== | ==References== | ||
Latest revision as of 21:01, 1 June 2023
Eosinophilic fasciitis, also diffuse fasciitis with eosinophilia, is a rare skin condition.[1]
General
Clinical:
- Onset typically preceded by strenuous exercise or labour.[2]
- Skin induration with "orange peel" appearance.[3]
- Eosinophilia.[3]
Treatment:[4]
- Corticosteroids.
- Methotrexate.
Microscopic
Features:[3]
- Diffuse fasciitis with eosinophilia.
Note:
- Require en bloc biopsies from the skin to the fascia.[2]
See also
References
- ↑ Shulman LE (1975). "Diffuse fasciitis with eosinophilia: a new syndrome?". Trans Assoc Am Physicians 88: 70–86. PMID 1224441.
- ↑ 2.0 2.1 "Eosinophilic fasciitis: From pathophysiology to treatment". Allergol Int 68 (4): 437–439. October 2019. doi:10.1016/j.alit.2019.03.001. PMID 30910631.
- ↑ 3.0 3.1 3.2 Mazilu D, Boltașiu Tătaru LA, Mardale DA, Bijă MS, Ismail S, Zanfir V, Negoi F, Balanescu AR (January 2023). "Eosinophilic Fasciitis: Current and Remaining Challenges". Int J Mol Sci 24 (3). doi:10.3390/ijms24031982. PMC 9916848. PMID 36768300. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916848/.
- ↑ Mazori DR, Femia AN, Vleugels RA (November 2017). "Eosinophilic Fasciitis: an Updated Review on Diagnosis and Treatment". Curr Rheumatol Rep 19 (12): 74. doi:10.1007/s11926-017-0700-6. PMID 29101481.